Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor

Molecular Endocrinology

Volumn 12, Issue 8, 1998, Pages 1161-1171

  Hong, S H ^a   Wong, C W ^a   Privalsky, M L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ONCOPROTEIN; PROTEIN TYROSINE KINASE; RETINOIC ACID RECEPTOR; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; GENE ACTIVATION; GENE REPRESSION; HORMONAL REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; SIGNAL TRANSDUCTION; SILENCER GENE; TRANSCRIPTION REGULATION;

EID: 0032230335     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.12.8.0160     Document Type: Article

References (64)

1. Thyroid hormone receptors: Multiple forms, multiple possibilities
2. The molecular biology of thyroid hormone action
3. Molecular mechanisms of action of steroid/thyroid hormone receptor superfamily members
4. Steroid hormone receptors: Many actors in search of a plot
5. Nonsteroidal nuclear receptors: What are genetic studies telling us about their role in real life?
6. The RXR heterodimers and orphan receptors
7. Overview: The nuclear receptor superfamily: The second decade
8. Nuclear hormone receptor coactivators and corepressors
9. A transcriptional co-repressor that interacts with nuclear hormone receptors
10. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor
11. Polarity-specific activities of retinoic acid receptors determined by a co-repressor
12. SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers
13. Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with Rev-erbA alpha and RVR: Physical association is dependent on the E region of the orphan receptors
14. Identification of TRACs (T3 Receptor-associating cofactors) a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors
15. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR
16. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains
17. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT
18. A conformational switch in nuclear hormone receptors is involved in coupling hormone binding to corepressor release
19. Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors
20. Stoichiometric and steric principles governing repression by nuclear hormone receptors
21. Differential recognition of liganded and unliganded thyroid hormone receptor by retinoid X receptor regulated transcriptional repression
22. Activation and repression by nuclear hormone receptors: Hormone modulates an equilibrium between active and repressive states
23. What's up and down with histone deacetylation and transcription?
24. Sinful repression
25. Transcriptional repression by the SMRT/mSin3 corepressor: Multiple interactions, multiple mechanisms, and a potential role for TFIIβ
26. The corepressor N-CoR and its variants RIP13a and RIP13Δ1 directly interact with the basal transcription factors, TFIIβ, TAFII32 and TAFII70
27. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL-6 oncoprotein
28. SMRT corepressor interacts with PLZF, and with the PML-RARα and PLZF-RARα oncoproteins associated with acute promyelocytic leukemia
29. Role of the histone deacetylase complex in acute promyelocytic leukemia
30. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukemia
31. Multiple mechanisms for regulation of steroid hormone action
32. Negative transcriptional regulation by nuclear receptors
33. Androgen receptor phosphorylation
34. Estrogen receptors: Bioactivities and interactions with cell signaling pathways
35. Mechanism of gene expression by the glucocorticoid receptor: Role of protein-protein interactions
36. Regulation of gene expression by nuclear hormone receptors
37. Modification of the retinoic acid signaling pathway by the catalytic subunit of protein kinase-A
38. Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP
39. A protein kinase C-dependent activity modulates retinoic acid-induced transcription
40. Phosphorylation of tyrosine 537 on the human estrogen receptor is required for binding to an estrogen response element
41. Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation
42. An alternative ligand-independent pathway for activation of steroid receptors
43. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
44. Thyroid hormone activation of transcription is potentiated by activators of cAMP-dependent protein kinase
45. Differential phosphorylation of chicken progesterone receptor in hormone-dependent and ligand-independent activation
46. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor
47. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta
48. Steroid hormone receptors and their regulation by phosphorylation
49. The nuclear corepressors NCoR and SMRT are key regulators of both ligand and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor
50. Signal transduction by receptors with tyrosine kinase activity
51. Role of the v-erb A and v-erb B oncogenes of avian erythroblastosis virus in erythroid cell transformation
52. Protein encoded by v-Erb A functions as a thyroid hormone receptor antagonist
53. Repression of transcription mediated by a thyroid hormone response element by the v-Erb A oncogene product
54. Transforming growth factor alpha
55. Physiological coupling of growth factor and steroid receptor signaling pathways: Estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor
56. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein
57. Interaction between erb B-receptors and heregulin in breast cancer tumor progression and disease
58. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells
59. Regulation of the dorsal morphogen by the Toll and torso signalling pathway: A receptor tyrosine kinase selectively masks transcriptional repression
60. A nuclear protein is required for thyroid hormone receptor binding to an inhibitory half-site in the epidermal growth factor receptor promoter
61. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT
62. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogn, 4-hydroxytamoxifen
63. Gene silencing by COUP-TF is mediated by transcriptional corepressors, N-CoR and SMRT
64. Dopamine activation of an orphan of the steroid receptor superfamily